Nonfusion Alternative To Artificial Discs Acquired By Abbott/Spinal Concepts
This article was originally published in The Pink Sheet Daily
Executive Summary
Abbott purchases Spine Next for $60 mil. plus milestone payments for commercializing the Wallis nonfusion spine stabilization device. Although Abbott touts Wallis as a less-invasive alternative to artificial discs for early degenerative disc disease, the firm plans a PMA submission for a disc of its own.